Business Description
Ascletis Pharma Inc
ISIN : KYG0520K1094
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 273.23 | |||||
Equity-to-Asset | 0.94 | |||||
Debt-to-EBITDA | -0.06 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 5.44 | |||||
Beneish M-Score | -4.1 | |||||
WACC vs ROIC |
Growth Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 13.2 | |||||
3-Year EBITDA Growth Rate | 10.8 | |||||
3-Year EPS without NRI Growth Rate | -7 | |||||
3-Year FCF Growth Rate | -1.4 | |||||
3-Year Book Growth Rate | -8.5 |
Momentum Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 32.93 | |||||
9-Day RSI | 30.29 | |||||
14-Day RSI | 31.93 | |||||
6-1 Month Momentum % | -5.88 | |||||
12-1 Month Momentum % | -41.39 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 16.58 | |||||
Quick Ratio | 16.54 | |||||
Cash Ratio | 16.35 | |||||
Days Inventory | 216.4 | |||||
Days Sales Outstanding | 76.19 | |||||
Days Payable | 42.95 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 1.8 | |||||
Shareholder Yield % | 0.66 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 45.92 | |||||
Operating Margin % | -530.45 | |||||
Net Margin % | -255.7 | |||||
FCF Margin % | -258.36 | |||||
ROE % | -5.79 | |||||
ROA % | -5.52 | |||||
ROIC % | -216.71 | |||||
ROC (Joel Greenblatt) % | -207.38 | |||||
ROCE % | -5.76 |
GF Value Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 21.4 | |||||
PB Ratio | 0.5 | |||||
Price-to-Tangible-Book | 0.53 | |||||
EV-to-EBIT | 7.54 | |||||
EV-to-EBITDA | 8.03 | |||||
EV-to-Revenue | -19.27 | |||||
EV-to-FCF | 7.46 | |||||
Price-to-Projected-FCF | 3.76 | |||||
Price-to-Net-Current-Asset-Value | 0.56 | |||||
Price-to-Net-Cash | 0.57 | |||||
Earnings Yield (Greenblatt) % | 13.26 | |||||
FCF Yield % | -12.94 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Ascletis Pharma Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil HK$) | 61.903 | ||
EPS (TTM) (HK$) | -0.148 | ||
Beta | 1.2 | ||
Volatility % | 45.45 | ||
14-Day RSI | 31.93 | ||
14-Day ATR (HK$) | 0.07023 | ||
20-Day SMA (HK$) | 1.3935 | ||
12-1 Month Momentum % | -41.39 | ||
52-Week Range (HK$) | 1.21 - 2.87 | ||
Shares Outstanding (Mil) | 1,012.76 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Ascletis Pharma Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Ascletis Pharma Inc Stock Events
Event | Date | Price(HK$) | ||
---|---|---|---|---|
No Event Data |
Ascletis Pharma Inc Frequently Asked Questions
What is Ascletis Pharma Inc(HKSE:01672)'s stock price today?
When is next earnings date of Ascletis Pharma Inc(HKSE:01672)?
Does Ascletis Pharma Inc(HKSE:01672) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |